enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. J&J, Bristol Myers lose challenges to US drug price ...

   www.aol.com/news/j-j-bristol-myers-lose...

   Blood thinners Eliquis from Bristol Myers and J&J's Xarelto were among the 10 drugs chosen last August for the first round of negotiations under the program, which was part of the 2022 Inflation ...

3. Rivaroxaban - Wikipedia

   en.wikipedia.org/wiki/Rivaroxaban

   Rivaroxaban, sold under the brand name Xarelto among others, is an anticoagulant medication (blood thinner) used to treat and prevent blood clots. [8] Specifically it is used to treat deep vein thrombosis and pulmonary emboli and prevent blood clots in atrial fibrillation and following hip or knee surgery. [ 8 ]

4. Does Medicare cover Xarelto? - AOL

   www.aol.com/lifestyle/does-medicare-cover...

   Xarelto is a brand name for the drug rivaroxaban. Parts of Medicare cover the cost of prescription medication, including Part A, Part D, and Advantage plans.

5. List of Johnson & Johnson products and services - Wikipedia

   en.wikipedia.org/wiki/List_of_Johnson_&_Johnson...

   Janssen COVID-19 vaccine [50] Neuroscience therapies Concerta [51] Invega [52] Ponvory [53] ... Xarelto [74] Invokana [75] Invokamet [76] Pulmonary hypertension therapies

6. List of largest selling pharmaceutical products - Wikipedia

   en.wikipedia.org/wiki/List_of_largest_selling...

   Drug Trade name Type Main indications Company Sales (USD millions/year) ∆ vs 2014 1 Adalimumab: Humira Biologic Rheumatoid arthritis: AbbVie Inc. 14,012 1,469 2 Ledipasvir/sofosbuvir: Harvoni Small molecule Hepatitis C: Gilead Sciences: 13,864 11,737 3 Etanercept: Enbrel Biologic Rheumatoid arthritis: Amgen. Pfizer. 8,697 4,009 4 Infliximab ...

7. FDA Turns Down J&J's Bid for Expanded Xarelto Use - AOL

   www.aol.com/news/2013-03-08-fda-turns-down-jjs...

   Health-care giant Johnson & Johnson recently released a press statement that said that the FDA has turned down its bid to receive approval to treat patients with acute coronary syndrome (ACS) with ...

8. Janssen Pharmaceuticals - Wikipedia

   en.wikipedia.org/wiki/Janssen_Pharmaceuticals

   In 1955, he and his team developed their first drug, Neomeritine (ambucetamide), an antispasmodic found to be particularly effective for the relief of menstrual pain. On 5 April 1956, the name of the company was changed to NV Laboratoria Pharmaceutica C. Janssen (named after Constant Janssen). On 27 April 1957, the company opened a new research ...

9. Bayer's patent for blood thinner Xarelto invalid, UK ... - AOL

   www.aol.com/news/bayers-patent-blood-thinner...

   Bayer's patent covering its best-selling blood thinner Xarelto is invalid, London's High Court ruled on Friday in a blow to the German drugmaker. The company's blockbuster Xarelto drug generated ...